Ophthalmology News

Ophthal

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bonnin P et al. - Intravitreal bevacizumab acutely improved VA and reduced central macular thickness in wet AMD. Ultrasound imaging revealed that BFVs decreased in all retrobulbar arteries, suggesting that after local diffusion, bevacizumab exerts a short-term regional effect. Bevacizumab might therefore induce hypoperfusion of the whole eye, which may correspond to a vascular side-effect.

Today in Clinical Pharmacology...keeping you current

Pharmacological and environmental factors in primary angle-closure glaucoma
British Medical Bulletin, 11/30/09

Preoperative intravitreal bevacizumab useful in trabeculectomy for neovascular glaucoma
Eye World, 11/30/09

Changing from bevacizumab to ranibizumab in age-related macular degeneration. Is it safe?
Clinical Interventions in Aging, 11/30/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address